Company: MBIO
Filing Date: 2025-04-01
Form Type: 424B3
Source: 0001104659-25-030657
Chunk: 258

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-01
Form: 424B3
Chunk 258
---

Companies’ Insider Trading Policy and to help prevent in advance any inadvertent violations of the federal securities laws, and
to avoid even the appearance of trading on inside information, we are implementing the following pre-clearance and compliance procedures.
Terms not otherwise defined herein have the meanings ascribed to them in the Companies’ Insider Trading Policy.

1.. Insiders and any other persons designated under our Insider Trading Policy or otherwise designated
by a Company Board of Directors may not engage in any transaction involving any of the Companies’ securities (including market or
private purchases or sales, option exercises, pledges, gifts, contributions to a trust, or any other transfers) without first obtaining
pre-clearance of the transaction from the Company’s Insider Trading Compliance Officer (or in his or her absence, the Chief Executive
Officer of the Company). A request for pre-clearance must be submitted via email as set forth below to the Company’s Insider Trading
Compliance Officer (or in his or her absence, the Chief Executive Officer of the Company) at least two days in advance of the proposed
transaction. You must state in the email that you do not possess, material non-public information. The Company’s Insider Trading
Compliance Officer (or in his or her absence, the Chief Executive Officer of the Company) will then determine whether the transaction
may proceed and, if so, provide a response via email and assist in complying with the new reporting requirements.

| ● | Requests by Fortress employees, officers and directors to trade in the securities of Fortress or any of the Companies: Fortress’ chief legal officer and principal financial officer (as of the date first above written, Samuel Berry at *** and David Jin at ***) |

| ● | Requests by employees, officers or directors of Avenue Therapeutics, Inc. (“Avenue”) to trade in the securities of Avenue: Fortress’ chief legal officer and principal financial officer (as of the date first above written, Samuel Berry at *** and David Jin at ***) |

| ● | Requests by employees, officers or directors of Avenue to trade in the securities of Fortress or any other affiliate: Fortress’ chief legal officer and principal financial officer (as of the date first above written, Samuel Berry at *** and ***) |

| ● | Requests by employees, officers or directors of Checkpoint Therapeutics, Inc. (“Checkpoint”) to trade in the securities of Checkpoint: Checkpoint’s principal |

​

​

​

financial officer (as of the date first
above written Garrett Gray at ***)

| ● | Requests by employees